As Originally | As | ||||||||
Filed | Restatement | Amended | |||||||
Balance sheet, as of September 30, 2013 |
|||||||||
Total Assets | $ | 83 | $ | 83 | |||||
Total Liabilities | $ | 343,743 | $ | 48,000 | $ | 295,743 | |||
Total Stockholders’ Equity | |||||||||
Preferred stock:
45,000,004
authorized; $0.0001
par value
104,955 and 0 shares issued and outstanding |
10 | 10 | |||||||
Common stock:
3,000,000,000
authorized; $0.00001
par value,
2,235,000,000 shares issued and outstanding |
22,645 | 295 | 22,350 | ||||||
Additional paid in capital | 17,625,417 | (17,185,977 | ) | 439,440 | |||||
Deficit accumulated during development stage | (17,943,732 | ) | (17,138,272 | ) | (805,460 | ) | |||
Total Stockholders' Deficit | (295,660 | ) | (48,000 | ) | (345,660 | ) | |||
Total Liabilities and Stockholders Deficit | $ | 83 | $ | 83 | |||||
Income statement | |||||||||
Net Loss | $ | 17,894,835 | $ | 17,138,272 | $ | 756,563 |